The role of the vesicular acetylcholine transporter (VAChT) in the regulation of cholinergic neurotransmission has not been fully elucidated. Here we sought to develop a tool for studying vesicular acetylcholine transporter function, and we present data on the validation of our new anti-VAChT antibody. We show that the immunoreactivity of the antibody is not due to an artifact of secondary antibody staining, and we present two additional validation data. First, the peptide epitope used to generate the antibody is able to block the binding of the anti-VAChT antibody in vivo. Further, RNA interference (RNAi) -mediated knockdown of VAChT function in cholinergic neurons drastically reduces anti-VAChT staining in those constructs. Additional evidence for the antibody functionality is presented in our research article on the subject (Boppana et al., 2017) [1].
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Experimental features
Samples were prepared using a protocol for whole-mount immunohistochemistry as described previously [2] . Briefly, Drosophila brains were dissected and immunostained as described elsewhere [1] . Imaging was then carried out using confocal microscopy as mentioned above. Data source location N/A Data accessibility
The data are with this article
Value of the data
Describes a key resource for dissecting cholinergic neuron function in specialized neural circuits in the Drosophila nervous system.
The data may be relevant for current efforts to map the circuitry of neurotransmitter systems within the brain.
Describes two independent RNAi knockdown fly constructs of VAChT in cholinergic neurons that can be used to test the biological function of VAChT in those neurons in vivo.
The in vivo peptide titration experimental procedure could be useful in validating other antibody reagents besides those developed against vesicular transporters.
Data
The data described here shows the specificity of the Drosophila anti-VAChT antibody. In Drosophila whole mount immunohistochemical preparations, we present data indicating that the VAChT antibody staining is not due to a secondary antibody artifact. Moreover, we show a dramatic reduction in VAChT immunostaining in fly constructs with an RNAi knockdown of VAChT expression in cholinergic neurons. Importantly, we present data on the titration of the VAChT antibody against the peptide that was used to generate the antibody. All of these data are available within this article.
Experimental design, materials and methods

Drosophila strains
Fly stocks w 1118 CS15, w; ChAT-Gal4,UAS-GFP (BDSC # 6793), yv; þ ; UAS-VAChT-RNAi (BDSC # 27684), and w
1118
, þ , UAS-VAChT-RNAi (VDRC # 40918) were used for the immunohistochemical assays. For the RNAi experiments, w; ChAT-Gal4;UAS-GFP was crossed into UAS-VAChT-RNAi and the progeny was stained for VAChT. The progeny of a cross between ChAT-Gal4, UAS-GFP and w 1118 CS15 was used as control. All stocks were maintained on standard corn meal media and raised at 25°C at a relative humidity of 50% (Figs. 1-3 ).
Peptide-titration immunohistochemistry
Wildtype fly brains were isolated and fixed in PFA as described elsewhere [1] . The epitope used as an antigen to generate VAChT antibody was diluted in the VAChT antibody to a 1:1 M ratio (see [1] ). This peptide-antibody mixture or VAChT antibody without any peptide (control) was allowed to incubate with fly brains overnight at 4°C. Brains were stained, mounted, and imaged as described below. 
Immunostaining and confocal microscopy
Immunostaining and confocal microscopy were performed as described previously, see [1] and [2] .
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